Plain-English translation of NCT07508020 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This clinical trial is testing a new medication called to see how it affects your appetite, how much you eat, and how your body processes food after meals. You would receive weekly injections under your skin, and researchers will carefully measure whether this treatment helps reduce hunger and food intake compared to a placebo (a dummy injection with no active medicine).
Current obesity treatments have limitations, and researchers are looking for new options that might help people feel less hungry and eat less. This early-stage study aims to understand how this medication works in the body before testing it in larger groups of people.
You likely qualify if…
You likely don't qualify if…
You would come to the clinic for screening visits to confirm you're eligible, then begin receiving weekly injections of either the new medication or placebo under your skin. Throughout the study, researchers would measure your appetite, monitor how much you eat, check your metabolism, and run blood tests and other assessments to see how the treatment affects your body. The entire trial would last several weeks, with regular visits to track how you're responding.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany